Results 71 to 80 of about 100,926 (300)
Efficacy of atypical antipsychotics in schizophrenia patients: effects of 5-HTR SNPs
Annals of General PsychiatryThe 5-hydroxytryptamine receptor (5-HTR) is a key protein responsible for the effects of 5-hydroxytryptamine (5-HT) and an important target for many antipsychotics.
Keying Liu +8 more
doaj +1 more source
Mechanisms of development of antipsychotic-induced metabolic disorders: pharmacogenetic aspect
Бюллетень сибирской медицины, 2018 Antipsychotics are the main drug group in the treatment of disorders of the schizophrenic spectrum. At the same time, this drug group requires long-term use, has a narrow therapeutic breadth and a large spectrum and high severity of undesirable drug ...
R. F. Nasyrova +4 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Improvement in medication adherence is often proposed as a potential advantage of pharmacogenetic‐guided prescribing over a traditional one‐size‐fits‐all approach. This paper provides a review of the published literature and presents the findings of studies that measure adherence to medication as an outcome of pharmacogenetic‐informed care, or that ...
Lucy Galloway +2 more
wiley +1 more source
, 2022 School of Nursing CapstonesThis article systemically reviews studies that present interventions related to pharmacological and non-pharmacological treatment for the weight management and reduction of pediatric patients prescribed antipsychotics.
Gaytan, Claudia
core +1 more source
Brazilian Journal of PsychiatryObjective: Due to the uncertainty whether atypical and typical antipsychotics have a stronger association with mortality among older people with schizophrenia, we examined the rates and causes of mortality in older adults with schizophrenia who take ...
Raphaëlle Haddad +7 more
doaj +1 more source
BMC Psychiatry, 2018 Background Metabolic abnormalities are common in patients maintained on antipsychotics. These abnormalities increase the risk of cardiovascular diseases and mortality in this population.
Samer Hammoudeh +14 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims This study aimed to improve the understanding of lithium's safety profile by analysing the frequency and distribution of reported adverse drug reactions (ADRs) compared to second‐generation antipsychotics (SGAs). Methods Individual case safety reports from VigiBase (1968–October 2023) involving individuals older than 2 years, with lithium or SGAs ...
Lisa T. Ringeling +8 more
wiley +1 more source
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
BMC Psychiatry, 2020 Background Prescription rates for long-acting injectable (LAI) antipsychotic formulations remain relatively low in Europe despite improved adherence over alternative oral antipsychotic treatments.
Maxine X. Patel +6 more
doaj +1 more source
Tackling cancer stemness with nanotechnology in the era of precision medicine
BMEMat, EarlyView.Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo +9 more
wiley +1 more source
Atypical antipsychotics in bipolar disorder: systematic review of randomised trials
BMC Psychiatry, 2007 Background Atypical antipsychotics are increasingly used for treatment of mental illnesses like schizophrenia and bipolar disorder, and considered to have fewer extrapyramidal effects than older antipsychotics.
Moore R Andrew, Derry Sheena
doaj +1 more source